Clinical Trials Browser

Phase 2/3 × Fluorouracil × 30 days × Clear all

NCT02135042 2026-03-18

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Phase 2/3 Active not recruiting

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT07437287 2026-02-27

CROCOBIL

Phase 2/3 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms